THE ROLE AND PLACE OF MEDICINAL PLANTS IN THE STRATEGIES FOR DISEASE PREVENTION by Sofowora, Abayomi et al.
Sofowora et al., Afr J Tradit Complement Altern Med. (2013) 10(5):210-229
http://dx.doi.org/10.4314/ajtcam.v10i5.2
210
THE ROLE AND PLACE OF MEDICINAL PLANTS IN THE STRATEGIES FOR DISEASE
PREVENTION
Abayomi Sofowora1, Eyitope Ogunbodede2 and Adedeji Onayade3
1C/O Department of Pharmacognosy, Obafemi Awolowo University, Ile-Ife, Nigeria. 2Department of
Preventive and Community Dentistry, Obafemi Awolowo University, Ile-Ife, Nigeria.3Department of
Community Health, Obafemi Awolowo University, Ile-Ife, Nigeria
E-mail: abayomisofowora@yahoo.com
Abstract
Medicinal plants have been used in healthcare since time immemorial. Studies have been carried out globally to
verify their efficacy and some of the findings have led to the production of plant-based medicines. The global market value of
medicinal plant products exceeds $100 billion per annum. This paper discusses the role, contributions and usefulness of
medicinal plants in tackling the diseases of public health importance, with particular emphasis on the current strategic
approaches to disease prevention. A comparison is drawn between the ‘whole population’ and ‘high-risk’ strategies. The
usefulness of the common-factor approach as a method of engaging other health promoters in propagating the ideals of
medicinal plants is highlighted. The place of medicinal plants in preventing common diseases is further examined under the
five core principles of the Primary Health Care (PHC) approach. Medicinal plants play vital roles in disease prevention and
their promotion and use fit into all existing prevention strategies. However, conscious efforts need to be made to properly
identify, recognise and position medicinal plants in the design and implementation of these strategies. These approaches
present interesting and emerging perspectives in the field of medicinal plants. Recommendations are proposed for strategising
the future role and place for medicinal plants in disease prevention.
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Introduction
The emphasis on the use of medicinal plants had hitherto been placed on the treatment rather than prevention of
diseases. However, there exists in the literature considerable report in recent times on research work on the use of medicinal
plants and their constituents in disease prevention. A World Health Organisation (WHO) Expert Group defined Traditional
Medicine as the sum total of all knowledge and practices, whether explicable or not, used in diagnosis, prevention and
elimination of physical, mental, or social imbalance and relying exclusively on practical experience and observation handed
down from generation to generation, whether verbally or in writing (WHO, 1976). For Africa, this may be extended further
by including an expression, such as ‘while bearing in mind the original concept of nature which includes the material world,
the sociological environment whether living or dead and the metaphysical forces of the universe’.
Over 90% of traditional medicine recipes/remedies contain medicinal plants but this paper will address,
specifically, the medicinal plants that have been implicated with preventive measures in disease control strategies. However,
it must be noted that only a very thin divide exists between treatment and prevention in some cases. A quick example is the
fact that by treating mild elevation of blood pressure renal disease can be prevented.
What is a medicinal plant?
A medicinal plant is any plant which, in one or more of its organs, contains substances that can be used for therapeutic
purposes or which are precursors for the synthesis of useful drugs. This description makes it possible to distinguish between
medicinal plants whose therapeutic properties and constituents have been established scientifically, and plants that are
regarded as medicinal but which have not yet been subjected to a thorough scientific study.
A number of plants have been used in traditional medicine for many years. Some do seem to work although there may
not be sufficient scientific data (double-blind trials, for example) to confirm their efficacy. Such plants should qualify as
medicinal plants. The term ‘crude drugs of natural or biological origin’ is used by pharmacists and pharmacologists to
describe whole plants or parts of plants which have medicinal properties. A definition of medicinal plants for the purpose of
this presentation should include the following (Sofowora 2008; Evans, 2008):
(a) plants or plant parts used medicinally in galenical preparations (e.g. decoctions, infusions, etc.) e.g. Cascara bark;
(b) plants used for extraction of pure substances either for direct medicinal use or for the hemi-synthesis of medicinal
compounds (e.g. hemi-synthesis of sex hormones from diosgenin obtained from Dioscorea yams);
(c) food, spice, and perfumery plants used medicinally, e.g. ginger;
(d) microscopic plants, e.g. fungi, actinomycetes, used for isolation of drugs, especially antibiotics. Examples are ergot
(Claviceps purpurea growing on rye) or Streptomyces griseus; and
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(e) fibre plants, e.g. cotton, flax, jute, used for the preparation of surgical dressings.
The growing importance of medicinal plants can be appreciated from the economic stand point when the following
facts are considered:
• Global trade in herbs is over USD 100 Billion per annum
• India and China’s medicinal plant trade is about two to five billion US dollars annually
• In Germany, it is over one billion US dollars annually
• Rose Periwinkle which is endemic to Madagascar fetches US$100 million per annum
• China trades in 7,000 species and 700,000 tons of medicinal plants per annum
• India trades in 7,000 species of medicinal plants
• Morocco exports 58.7 tons of medicinal plants annually
• In the last 5 years, sales of medicinal plants doubled in China, tripled in India and grew by 25% in Europe.
A Presidential Initiative Committee on the Development, Promotion, and Commercialisation of Nigerian Herbal
Medicinal Products was inaugurated on 30th May 2006 and was given a target of US$1billion sales of medicinal plants and
its products within 10 years for Nigeria. Based on current research and financial investments, medicinal plants will,
seemingly, continue to play an important role as a health aid (Hoareau and DaSilva, 1999). The use of traditional medicine
and medicinal plants in most developing countries, as a normative basis for the maintenance of good health, has been widely
observed (UNESCO, 1996). Furthermore, an increasing reliance on the use of medicinal plants in the industrialised societies
has been traced to the extraction and development of several drugs and chemotherapeutics from these plants as well as from
traditionally used rural herbal remedies (UNESCO, 1998). Moreover, in these societies, herbal remedies have become more
popular in the treatment of minor ailments, and also on account of the increasing costs of personal health maintenance.
Indeed, the market and public demand has been so great that there is a great risk that many medicinal plants today face either
extinction or loss of genetic diversity.
Preventive strategies
Health promotion, disease prevention and chronic disease management are proactive approaches to health care that
stresses prevention at different points along the health care continuum. Health promotion and disease prevention strategies
focus on keeping people well and preventing diseases from occurring. These strategies are referred to as primary prevention
activities. Prevention is categorised into three levels (Commission on Chronic Illness, 1957):
(1) Primary Prevention, which seeks to decrease the number of new cases of a disorder or illness. At this level of
prevention we have:
 Health promotion/education, and
 Specific protective measures (such as immunisation)
(2) Secondary Prevention, which seeks to lower the rate of established cases of a disorder or illness in the population
(prevalence). This level essentially involves measures that ensure early diagnosis (such as screening) and prompt
management
(3) Tertiary Prevention, which seeks to decrease the amount of disability associated with an existing disorder. This
level involves:
 Disability limitation and
 Rehabilitation
The secondary and tertiary prevention activities focus on maintaining the health of individuals with chronic
conditions, delaying progression of their conditions, and preventing complications.
Disease prevention should focus on strategies that reduce the risk of disease, identify risk factors, or detect disease
in its early, most treatable stages. Examples of disease prevention activities include well-baby visits, immunisations, calcium
and Vitamin D supplements to reduce the risk of osteoporosis, blood pressure and cholesterol assessments during annual
health exams, and screening for illnesses such as breast, cervical, colorectal and prostate cancer (Family Health Teams,
2006).
Public health, diet, food production and the environment are deeply interrelated, and understanding these
relationships is crucial in pursuing a liveable future. Sometimes therefore, there is only a thin line between treatment and
prevention of certain diseases. For example, treatment of mild hypertension will prevent many chronic renal diseases. This is
also true for obesity, cancers, coronary heart diseases (CHDs) as well as diabetes and its sequelae, though these are non-
communicable diseases.
The burden of healthcare and its human and financial resources requirement
In developing countries all over the world, large numbers of people die daily of preventable or curable diseases
because of the lack of even simple health care. Diseases in these countries are often associated with malnutrition. As a result,
those that do survive often never recover completely from the effects. The developing world is not a homogenous entity, but
is made up of a variety of widely differing countries and areas which are at different stages of development. Nevertheless,
these developing countries have certain features in common, including extremely limited resources, poor communications,
vast distances, low levels of education, and individual and community poverty. These factors act together to keep these
countries in a perpetual state of poverty. Yet, their populations continue to rise, especially in the rural regions which usually
account for about 80 per cent of the total population.
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Another special characteristic of the developing world is the nomadic lifestyle of some of its people. Some 50 to
100 million nomads have been estimated to be present in the world, and 90 per cent of these live in Africa or Asia. Nomads
have their own needs and problems peculiar to their lifestyle. Because of their constant movement and dispersion it is
difficult for conventional health services to reach these people. The striking difference between the developed and the
developing world in terms of health care is reflected in the differing life expectancy of their populations. For example,
according to WHO (2012), in 2009 the life expectancy at birth was estimated at 51 years in Angola and Burkina Faso, while
for Malawi it was 47 years (African countries) compared with 80 years in the United Kingdom, USA and Austria. Although
the situation is improving in some African countries, this gap is still wide. Twenty-six African countries are ranked among
the ‘Low Income Group’, 17 in the ‘Lower Middle Income Group’ and 9 in the ‘Upper Middle Income Group’, while only
Equatorial Guinea is ranked in the ‘High Income Group’ (WHO, 2012). Several of the people in Africa earn less than US$2
per day.
Any strategy for disease prevention in the developing countries, especially in Africa, must take these
socioeconomic factors into account. With the abundant biodiversity of plants in the African Region and the relative lower
cost of using plant derived medicines instead of processed synthetic drugs, medicinal plants should have a role to play in
disease prevention strategies in Africa.
Strategies planned for traditional medicine development (First decade and second decade for Traditional Medicine in
Africa)
For WHO, the main principles of the strategy for developing traditional medicine (TM) globally were thus:
 Policy: Integrate TM/CAM with national health care systems, as appropriate, by developing and implementing
national TM/CAM policies and programmes
 Safety, efficacy and quality: Promote the safety, efficacy and quality of TM/CAM by expanding the knowledge-
base on TM/CAM, and by providing guidance on regulatory and quality assurance standards
 Access: Increase the availability and affordability of TM/CAM, with an emphasis on access for poor populations
 Rational use: Promote therapeutically sound use of appropriate TM/CAM by providers and consumers
Strategies for development of TM in the African Region (WHO-AFRO, Brazzaville)
For WHO-AFRO, the priority interventions for the development of TM during first and second decades (i.e. 2001-2010 and
2011-2020) for African TM are as follows:
 Policy formulation;
 Capacity building;
 Research promotion;
 Support for the local production of Traditional Medicines including cultivation of medicinal plants;
 Protection of intellectual property rights and traditional medical knowledge.
Global Disease Burden
Diseases have been grouped as communicable or non-communicable based on the involvement or otherwise of a
transmissible biologic disease causing agent. Until recently, communicable diseases (CDs) were the major causes of ill-health
and deaths in the developing (low and middle resource) countries while non-communicable diseases were prevalent in the
developed (high resource) countries, where improvement in living conditions and widespread deployment of technology had
brought the CDs under control. However, the optimism that communicable diseases would be less of a health problem in the
developed countries appears to have been misplaced with the appearance of new infectious diseases and re-emergence of
older disease agents. Similarly, non-communicable diseases are already a major cause of morbidity and mortality as a
consequence of globalisation and changing lifestyle in developing countries. Globally therefore, NCDs and CDs account for
about equal quantities of morbidity and mortality, thus making all countries to currently face the double disease burden. The
overall picture is, however, graver for low and middle income countries in terms of the health and socio-economic impacts.
For example, estimates of projected causes of all deaths for the African Region indicate that injuries and chronic
communicable diseases accounted for 30% of all deaths for 2005. (Figure 1)
Medicinal plants and disease prevention
Strategies for the Prevention of Communicable diseases
Three core approaches – surveillance, outbreak investigations and immunisation – are fundamental to the
prevention of communicable diseases. While medicinal plants may appear to have limited role in these approaches, several
medicinal plants and traditional medicines derived from them have been used to enhance immune response to several disease
agents (Di Pierro et al., 2012; Ramakrishna et al., 2011).
Strategies for Prevention of Non-Communicable Diseases
The WHO 2008 to 2013 Action Plan for the Global Strategy for the Prevention and Control of NCDs articulated an
intersectoral, multi-level plan to curb the rising global prevalence of NCDs with particular focus on the low and middle
income countries. The overall foci of the plan were to
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 map the emerging NCD epidemic and ascertain their social, economic, behavioural and political determinants;
 reduce the level of exposure of individuals and population to the common modifiable risk factors – tobacco use,
unhealthy diet, physical inactivity, etc.; and
 strengthen health care for people with non-communicable diseases through the development of evidence-based
norms, standards and guidelines for cost effective interventions.
Related to the third focus above, an examination of the causal chain of risk factors for NCDs (Figure 2) is helpful in
illuminating the potential role of medicinal plants in the prevention of NCDs. Medicinal plants have specific roles in
strengthening health care opportunities for people with NCDs as well as in the management of the biologic risk factors for
NCDs, especially in the early stage (Jung et al., 2012; Tan et al., 2010).
Figure 1: Projected deaths by cause, all ages, WHO African Region, 2005
Source: Moeti (2008). Data estimated by WHO using standard methods to maximize cross-border comparability. They are
not necessarily the official statistics of Member States.
Figure 2: Causal chain of risk factors for NCDs
The ‘whole population’ and ‘high-risk’ strategies
Two main types of approaches have been advocated in tackling major public health problems. The whole-
population strategy targets the community as a whole to control the occurrence of new diseases in the population. The high-
risk strategy on the other hand aims to identify individuals most at risk for a disease or outcome and then target preventive
efforts at that group. These were first defined by Geoffrey Rose (Rose, 1985). In promoting the use of medicinal plants in
disease prevention, the whole-population strategy will have the global community as the target, whereas the high-risk
strategy may focus on rural communities, especially in the developing countries. It may also on the other hand wish to focus
on refining medicinal plants for use in specific disease conditions that presently defy conventional treatment, such as cancer,
HIV infection and AIDS.
Utilising the Common Factor approach
The common risk factor approach aims at bringing together several health promoters working on eliminating
common-risk factors as a way of preventing diseases. (Sheiham and Walt, 2000) Poor Diet for example can lead to obesity,
Behavioural Risk Factors
 Tobacco
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 Physical Inactivity
 Unhealthy Diet
Biologic Risk Factors
 Obesity
 Raised Blood
Pressure
 Elevated Blood Sugar
 High Cholesterol
Non-Communicable Diseases
 Cardiovascular Diseases
 Stroke
 Diabetes mellitus
 Cancers
 Chronic respiratory diseases
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diabetes, cancers, and dental caries. Hence, nutritionists, diabetologists, oncologists, dental practitioners can work together
with diet as common theme. A modified form of this approach (Figure 3) can be a useful tool in engaging other health
promoters, in tackling the different forms of disease, and in propagating the ideals of medicinal plants. Working with various
groups, for example, appropriate medicinal plants can be incorporated into the diets to alleviate disease and suffering. This
approach will enable those working to promote the use of medicinal plants to collaborate with other health promoters in areas
such as malaria, diabetes, cancers, cardiovascular diseases, tuberculosis, HIV/AIDS, oral diseases, dermatological problems,
etc.
Incorporating the oral health promotion
model as outlined in the Ottawa charter will
also be useful. (Figure 4)
Figure 3: The Common Factor Approach (Adapted from Sheiham and Walt, 2000)
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Figure 4: A Health Promotion Model for Medicinal Plants (Adapted from Nutbeam, 1998)
The Primary Health Care (PHC) Approach
Primary Health Care was defined in Alma Ata (WHO, 1978) as essential care based on practical, scientifically
sound and socially acceptable method and technology made universally accessible to individuals and families in the
community through their full participation and at a cost they and the country can afford to maintain in the spirit of self-
reliance and self-determination. The PHC philosophy recognises that each discipline contributes to health and health services
delivery within a PHC model, both in a unique sense and through collaborative interdisciplinary practice.
The five core principles of the PHC approach include the following:
- Equitable distribution
- Community Participation (as issues that local people identify rather than predetermined services introduced by
professionals, working within existing community organisations and local government structures, etc.)
- Focus on Prevention
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- Appropriate Technology
- Multisectoral Approach – Emphasis should be made that the reason for the failure of many programmes is due to
the fact that they operate in isolation, separate from the general health care structure and without the support of other relevant
sectors. The need for programme cooperation and collaboration cannot be over-emphasised.
The elements (or components) of PHC include (but not limited to) Immunisation, Maternal and Child Health
(MCH) Care, Essential Drugs, Food and Nutrition, Education, Common Illnesses and injury, Water and Sanitation, Endemic
Infectious Diseases, Mental health and Oral health.
All African countries have adopted PHC as the over-arching strategy to achieve health for their citizens. Strategies
for the promotion of medicinal plants for the prevention of diseases in Africa must therefore take into cognisance the PHC
approach. It must essentially follow the 5-key principles outlined above and be integrated into the elements. Medicinal plants
will be useful for Maternal and Child health care, as essential drugs, in food and nutrition, for common illnesses and injury,
for endemic infectious diseases, mental health and oral health.
Medicinal plants also fit perfectly into the modelling for priorities in Primary Health Care as proposed by
McDonald and Ollerenshaw (2011). (Figure 5)
Figure 5: Model for Priority setting in Primary Health Care (McDonald & Ollerenshaw, 2011)
In summary, from the above considerations of available strategies, medicinal plants can play vital roles in disease
prevention and their promotion and use fit into all existing prevention strategies. However, conscious efforts need to be made
to properly identify, recognise and position medicinal plants in the design and implementation of these strategies. These
approaches present interesting and emerging perspectives in the field of medicinal plants.
Ethnobotanical Studies on Medicinal Plants Used in Disease Prevention
In order that a comprehensive compilation of medicinal plants that can be used in disease prevention is obtained,
collation of original data from the traditional custodians of such knowledge is essential (Tan et al., 2010). This is especially
so in the case of African Traditional Medicine (ATM) where information is passed on from generation to generation orally
about the plants used. Unlike in Chinese Traditional Medicine (CTM) and the Indian systems of medicine (Ayurveda, Unani
and Sithda) where the information is available in books (and now online), a lot of the information on African traditional
medicine is yet to be documented. Efforts are, however, being made by WHO-AFRO to augment the various isolated
databases on medicinal plants through the provision of guidelines for documentation of herbal recipes (WHO/AFRO 2012).
Specific ethnobotanic surveys at village level using some of the methods described by Sofowora (2008) can be used. Such a
survey by Biswas et al. (2011) on medicinal plants used for preventive medicinal purposes in Muktipara village, Chuadanga
District of Bangladesh yielded 11 authentic plants including Azadirachta indica and Moringa oleifera which are quite
common in Africa.
Sofowora et al., Afr J Tradit Complement Altern Med. (2013) 10(5):210-229
http://dx.doi.org/10.4314/ajtcam.v10i5.2
216
A similar survey conducted by Rahmatulla et al. (2011) among the Chakma residents of Hatimara (south) village of
Rangamati district, also in Bangladesh, indicated that the mode of consumption of the plants differed to some extent. Some
plants, like Spilanthes calva or Commelina paludosa, the leaves were boiled, mixed with crushed peppers and taken. The
authors found that the addition of peppers did not serve any therapeutic purposes. Rather, peppers, particularly hot peppers,
were added to make the dish more palatable and to impart flavour to the dish (Rahmatullah et al., 2009; Sofowora 2008;
Abel and Busia, 2005). The juice of young leaves of Centella asiatica or juice of leaves of Solena amplexicaulis was taken in
the raw state. The fruits of Gymnopetalum cochinchinense were used for prevention of ulcer, and Solanum torvum as a
preventive measure against leucorrhoea, typhoid and tonsillitis. The barks and seeds of Saraca were mashed and taken in the
raw state as prevention for irregular menstruation and menorrhagia.
International ethnobotanical surveys sponsored by ACCT (Agence de Cooperation Culturelle et Technique) into 17
Francophone African countries and 5 into Anglophone African countries sponsored by the African Union (AU/STRC) and
most of which were led by Professor Edouard Adjanohoun (Benin now France) and Professor Laurent Ake Assi have been
published. These need to be searched for plants used in disease prevention as they were general ethnobotanic surveys which
probably emphasised more enquiries on the use of plants to treat disease. All the data from such surveys especially the new
ones need to be stored in a database where it is not yet done and protected for only authorised access.
Medicinal plants used to prevent cancer
Yasukawa (2012) has reviewed the chemopreventive activity of natural sources, foods, supplements, crude drugs
and Kampo medicines (traditional Japanese herbal prescriptions). In that review, he observed that cancer chemoprevention is
currently one of the most urgent projects in public health. Cancer chemoprevention is defined as the use of specific natural
and synthetic chemical agents to reverse or suppress carcinogenesis and prevent the development of invasive cancers.
Recently, dietary non-nutrient compounds have demonstrated important effects as chemo-preventive agents, and considerable
work on the cancer chemopreventive effects of such compounds in animal models has been undertaken. Epidemiological
surveys have shown that the majority of human cancers are related to two factors, namely, diet and smoking (Banning, 2005;
Hirayama, 1984). However, in the general population, daily consumption of certain foods has also been shown to have
anticancer effects. This highlights the importance of environmental factors such as diet in cancer chemoprevention (Banning,
2005). An understanding of the mechanisms of carcinogenesis is essential for cancer chemoprevention. Most cancer
prevention research is based on the concept of multistage carcinogenesis: initiation → promotion → progression (Pitot and 
Dragan (1991)]; Morse and Stoner, 1993). (Figure 6)
www.intechopen.com (Yasukawa, 2012)
Figure 6: Stages in Cancer Prevention Research
In contrast to both the initiation and progression stages, animal studies have indicated that the promotion stage
occurs over a long time period and may be reversible, at least early on. For this reason, it is expected that inhibition of tumour
promotion should be an efficient approach to cancer control (Murakami, et al., 1996). Yasukawa and his team have found in
the search for potential anti-tumour promoters (cancer chemopreventive agents) from edible plants and fungi, and from crude
drugs, that various triterpene alcohols and sterols and their oxygenated derivatives showed inhibitory effects on mouse ear
inflammation induced by 12-Otetradecanoylphorbol-13-acetate (TPA). Primary prevention of cancer aims to avoid the
development of cancer. Therefore, initiation and/or promotion of carcinogenesis should be inhibited. However, the adult
population bears tumour cells that cannot revert to normal cells, and thus effective strategies to prevent cancer include
avoiding continuous contact between these cells and promoters and/or aggressively inhibiting the tumour promoter effects.
Therefore, to prevent cancer, it is essential to find plants that contain effective compounds (anti-tumour promoters) that
delay, inhibit or block tumour promotion, which is a reversible and long-term process (Yasukawa, 2012). A few examples of
such plants of interest are shown below:
(Pygeum) Prunus spp (Family Rosaceae) e.g. African Prune or African Plum Tree
Prostate cancer is a very good example for chemoprevention because prostate cancer is typically slow growing and
is usually diagnosed in elderly males. The extract of the bark of Pygeum africanum (Prunus Africana) has been used in
Europe as a prevention and treatment of prostate disorders including benign prostatic hypertrophy (BPH). In tissue culture,
ethanolic extracts (30%) of the bark inhibited the growth of PC-3 and LNCaP cells; induced apoptosis and altered cell
kinetics; down-regulated ERalpha and PKC-alpha protein, and demonstrated good binding ability to both mouse uterine
oestrogen receptors and LNCaP human androgen receptors. TRAMP mice fed with P. africanum showed a significant
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reduction (P = 0.034) in prostate cancer incidence (35%) compared to casein fed mice (62.5%). P. africanum therefore has a
significant role in regulation of prostate cancer both in vitro and in vivo and therefore may be a useful supplement for people
at high risk for developing prostate cancer (Shenouda et al, 2007). Katz (2002) had observed that the consumption of
isoflavones found in legumes and other plants is related to lower rates of BPH and prostate cancer among Asian men (Katz,
2002). The methanol extract of Prunus jamasakura Sieb. ex Koidz. inhibited two-stage carcinogenesis by DMBA/TPA in
mouse skin (Yasukawa, et al., 1998). Octacosyl ferulate, from the active fraction of the plant, inhibited tumour promotion by
DMBA/TPA in mouse skin (Yasukawa, et al., 1998) (Figure 7). The compound also inhibited the phosphorylation of histone
by protein kinase C (PKC) in a concentration-dependent manner.
Figure 7: Octacosyl ferulate from Pruni Cortex
Azadirachta indica (Family Meliaceae) Neem
Over 60 different types of biochemicals including terpenoids and steroids have been purified from this plant. The
anticancer properties of the plant have been studied largely in terms of its preventive, protective, tumour-suppressive,
immunomodulatory and apoptotic effects against various types of cancer and their molecular mechanisms (Paul et al, 2011).
Triple-negative breast cancer (TNBC) accounts for 15-20% of all breast tumours and these breast tumours are usually
aggressive and highly metastatic. Unfortunately, treatment options for TNBCs are limited. A novel compound, 2'-3'-
dehydrosalannol (DHS) isolated from A. indica uncrushed leaves, inhibited growth and induced apoptosis in TNBC cell lines.
Molecular analysis suggested that DHS inhibited cathepsin-mediated pro-survival signalling [pAKT: phosphorylated protein
kinase B; BCL-2: B-cell lymphoma 2 and cyclin D1] and induced pro-apoptotic markers such as BAX [BCL-2-associated X
protein] and cleaved caspase-3 (Boopalan et al, 2012, Malathi et al, 2002). Also, Neem leaves were found to inhibit tumour
promotion by DMBA/TPA in mouse skin (Arora et al., 2011). Inhibition of carcinogenesis in response to neem treatment was
accompanied by an over expression of signal transducer and activator of transcription 1 (STAT1) and activator protein 1 (AP-
1) and decrease in nuclear factor-kappa B (NF-κB) expression (Arora et al., 2011). In a recent study, Bharati et al, (2012)
evaluated the anticarcinogenic potential of aqueous A. indica leaf extract against N-nitrosodiethylamine (NDEA)-induced
hepatocarcinogenesis. They reported a significant reduction in tumour incidence (33%), tumour multiplicity (42%), and
increase in survival (34%) upon administration of the aqueous extract to NDEA-abused mice. Transmission and scanning
electron microscopic investigations showed severe alterations in organelle organisation, cellular arrangement, degree of
differentiation, cellular metabolism, and morphology of the hepatocytes. They concluded that these changes appeared to be
distinctly delayed upon supplementation with the leaf extract of the plant. The results suggest that A. indica may have
anticancer potential against NDEA-induced hepatic cancer.
Rosmarinus officinalis L (Family Labiatae) Rosemary
Colorectal cancer is the second leading cause of cancer death in Australia. Ngo et al. (2011) reviewed scientific
evidence from all studies published from 1996 to March 2010 and which examined the protective effects of rosemary on
colorectal cancer and other types of cancer. They concluded that evidence from animal and cell culture studies demonstrates
the anticancer potential of rosemary extract as well as only the following constituents of it: carnosol, carnosic acid, ursolic
acid, and rosmarinic acid. The reported anticancer properties were found to arise through the molecular changes in the
multiple-stage process of cancer development, which are dose related and not tissue or species specific. López-Jiménez
(2013) demonstrated that the anti-angiogenic activity of carnosol and carnosic acid could contribute to the chemopreventive,
antitumoral and antimetastatic activities of rosemary extracts and suggested their potential in the treatment of other
angiogenesis-related malignancies. Ursolic acid and carnosol were isolated from the methanol extract of Rosemary, and
inhibited DMBA/TPA-promoted two-stage carcinogenesis in mouse skin (Huang et al., 1994) (Figure 8).
.
Figure 8: Terpenoids from
rosemary
Vitis vinifera L. (Family Vitaceae) Grape
Dietary intake of foods rich in antioxidant properties is suggested to be cancer protective. Foods rich in antioxidant
properties include grape (Vitis vinifera). Grape skin and seed extracts exert strong free radical scavenging and chelating
activities and inhibit lipid oxidation in various food and cell models in vitro. The use of grape antioxidants are promising
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against a broad range of cancer cells by targeting epidermal growth factor receptor (EGFR) and its downstream pathways,
inhibiting over-expression of COX-2 and prostaglandin E2 receptors, or modifying oestrogen receptor pathways, resulting in
cell cycle arrest and apoptosis (Zhou and Raffoul, 2012).
Filip et al. (2011) in their studies on Photoprotective effects of two natural products on ultraviolet B-induced
oxidative stress and apoptosis in SKH-1 mouse skin reported that their results suggest that Calluna vulgaris and Vitis vinifera
extracts might be chemopreventive candidates for reducing UV-induced risk for skin cancer.
Currants and Sultanas (Vitis vinifera L.) are dried vine products produced in Greece. Kaliora et al. (2008)
investigated the gastric cancer preventive activity of methanol extracts obtained from currants from three different origins in
Greece (Vostizza, Nemea, and Messinia), as well as methanol extracts obtained from Sultanas cultivated on the island of
Crete as to inhibition of cell proliferation, induction of apoptosis, and inhibition of inflammation. All extracts from 500
micrograms of dried raisins studied suppressed cell proliferation, significantly those obtained from Sultanas from Crete and
currants from Nemea. The French eat higher levels of animal fat, but their incidence of heart disease remains surprisingly
low. This ‘French Paradox’ is thought to be due to the benefits they derive from consuming red wine. The ethanol extract of
grapes inhibited tumour promotion by DMBA/TPA in mouse skin (Alam et al., 2002). Resveratrol, in a dose-dependent
manner, reduced the incidence, total number and multiplicity of visible hepatocyte nodules (Bishayee and Dhir, 2009) (Figure
9).
Figure 9: Resveratrol from grape
On the other hand, grape seeds are a rich source of monomeric, dimeric and oligomeric proanthocyanidins. The
polyphenolic fraction of grape seeds suppressed tumour promotion by DMBA/TPA in mouse skin (Bomser, et al., 1999;
Zhao, et al., 1999).
Glycine max or G. soya (Family Leguminosae) Soya milk
Genistein, the most abundant phytoestrogen in soybeans, may bind to oestrogen receptors and perform anticancer
activities. Choriocarcinoma is a malignant, trophoblastic and aggressive cancer of the placenta. Liu et al (2011) investigated
the effect of genistein on the invasive potential of the choriocarcinoma cell line JAR and its underlying mechanism and found
that genistein inhibited JAR cell invasion in a dose-dependent manner by a matrigel invasion assay. Their findings have
significant implications for the prevention and therapy of choriocarcinoma. However, Khan et al (2012) tested the hypothesis
that Soy isoflavone consumption may protect against breast cancer development. They found a lack of efficacy for breast
cancer prevention and a possible adverse effect in premenopausal women. Soy milk inhibited 4-(methylnitrosamino)-1-(3-
pyridyl)-1-butanoneinduced mammary carcinogenesis in rats (Ohta et al., 2000). Soy beans contain high amounts of
isoflavonoids and saponins; isoflavonoids have been shown to have phytoestrogenic activity (Moliteni et al., 1995; Katz,
2002).
Zingiber officinale Roscoe (Family Zingiberaceae) Ginger
Dehydrozingerone a pungent constituent of ginger is a vanillyl ketone. Structurally, it is representative of half the
chemical structure of curcumin which is a promising phytochemical for the inhibition of malignant tumours, including colon
cancer. Yogosawa et al. (2012) evaluated the antiproliferative effects of dehydrozingerone against HT-29 human colon
cancer cells, and it was found that it dose-dependently inhibited growth at the G2/M phase with up-regulation of p21.
Dehydrozingerone additionally led to the accumulation of intracellular ROS, although most radical scavengers could not
clearly repress the cell-cycle arrest at the G2/M phase. Their results suggest that analogues of dehydrozingerone may be
potential chemotherapeutic agents for colon cancer (Škrovánková, 2012). Kurapati et al. (2012) investigated the
combinatorial cytotoxic effects of Curcuma longa and Zingiber officinale on the PC-3M prostate cancer cell line. The two
extracts separately showed significant inhibitory effects on colony-forming ability. However, when both the agents were
tested together at the same concentrations, the combined effects were much more significant than their individual ones,
suggesting the role of multiple components and their synergistic mode of actions to elicit stronger beneficial effects.
Hexahydrocurcumin, extracted from Zingiber officinale, was shown to be cytotoxic to colorectal cancer cells by
Chen et al. (2011). Treatment of SW480 cells with hexahydrocurcumin (100 microM) resulted in a massive accumulation of
the cells in the G1/G0 phase of the cell cycle. This compound could prove useful in cancer prevention.
The protective and/or preventive activity of various spices against various cancers and gastric ulcer has been
reviewed by Sumbul et al. (2011) and by Sung et al. (2012).
Topical application of an ethanol extract of ginger inhibited TPA-induced tumour promotion during two-stage
carcinogenesis in mouse skin (Katiyar et al., 1996). Pre-application of an ethanol extract of ginger onto the skin of SENCAR
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mice resulted in significant inhibition of TPA-induced epidermal ODC, COX and lipoxygenase activities as well as ODC
mRNA expression in a dose-dependent manner. Topical application of [6]-gingerol inhibited tumour promotion by
DMBA/TPA in mouse skin, and also suppressed TPA-induced epidermal ODC activity and inflammation (Park et al., 1998)
(Figure 10).
Figure 10: Some phenolics from Zingiber officinale
Food Supplements
Allium cepa and A. sativum (Family Liliaceae) Onion and Garlic
Antony and Singh (2011) have reviewed the mechanisms and targets of cancer chemoprevention by diallyl
trisulfide (DATS) extracted from Allium species, while Zhou et al (2011) in a meta-analysis, in which they pooled analysis of
all studies, concluded that the consumption of large amounts of Allium vegetables (in a comparison of the highest and lowest
consumption groups) reduced the risk for gastric cancer (odds ratio, 0.54; 95% confidence interval, 0.43-0.65). Allium
sativum (garlic) and its chemical constituents, especially Allicin, ,Dially Disulfide, Diallyl Trisulfide, have also been shown
in recent studies to be chemopreventive agents for lung cancer and breast cancer (Chu et al., 2012; Nkrumah-Elie et al.,
2012; Li et al., 2012). Allicin was also reported by Wang et al. (2012) to induce apoptosis in EL-4 cells in a time- and
concentration-dependent manner, in which the mitochondrial pathway might play a central role.
Onion oil inhibited tumour promotion by DMBA/TPA (Belman, 1983; Perchellt et al., 1990) and by BP/croton oil
(Sadhana et al., 1988) in mouse skin, while garlic oil inhibited tumour promotion by DMBA/TPA in mouse skin (Belman,
1983; Perchellt et al., 1990).
Panax ginseng C.A. Mayer (Family Araliaceae). Ginseng
Li et al. (2012) characterised a homogeneous polysaccharide (PGPW1) from the root of Panax ginseng with
molecular weight as 3.5×10(5) Da. PGPW1 contained Glcucose, Galactose, Mannose and Arabinose in the molar ratio of
3.3:1.2:0.5:1.1. It dose-dependently displayed potent anti-proliferation and anti-metastatic activities. They also found that the
attenuated expression of M3 muscarinic receptor on the surface of T24 cells by PGPW1 would contribute to its antitumour
functions. All the data indicated the potential of its clinical application for the prevention and treatment of bladder cancer
metastasis. Dong et al. (2011) have evaluated the cytotoxic potency of ginsenosides and their synthetic derivatives against a
variety of cancer cells with a view to determining the structure activity relationship. The results clearly indicated that the
compound with less polar chemical structures possesses higher cytotoxic activity towards cancer cells. In their own
investigation on ginsenoside Rp1, Kang et al. (2011) found that it inhibited breast cancer cell proliferation and inhibited both
anchorage-dependent and -independent breast cancer cell colony formation. In addition, Rp1 induced cycle arrest and
apoptosis-mediated cell growth suppression. Rp1 also decreased the stability of the IGF-1R protein in breast cancer cells.
They therefore suggested that Rp1 has potential as an anticancer drug and that IGF-1R is an important target for treatment
and prevention of breast cancer. In their own studies, Cui et al. (2010) found that when American ginseng was tested using
the azoxymethane (AOM)/dextran sulphate sodium (DSS) mouse model of ulcerative colitis, they demonstrated that ginseng
can suppress colon cancer associated with colitis.
Oral administration of white and red ginseng (Panax ginseng C.A. Mayer) suppressed colon carcinogenesis by 1,2-
dimethylhydrazine (DMH) in rat (Fukushima, et al.,2001). The ginsenosides Rg3, Rg5 and Rh2 are active components in
ginseng, and act either singularly or synergistically in cancer prevention (Yun, et al., 2001). The methanol extract of san-chi
ginseng (P. notoginseng (Burk.) F.H. Chen) suppressed skin carcinogenesis by DMBA/TPA, liver carcinogenesis by
DEN/Phenobarbital, lung carcinogenesis by 4NQO/glycerol in mice (Konoshima et al., 1996). Moreover, the methanol
extract of san-chi inhibited skin carcinogenesis by NOR-1/TPA, as well as DMBA/fumonisin B1 in mice (Konoshima et al.,
1999). The ginsenoside Rg1 slightly suppressed tumour promotion by DMBA/TPA in mouse skin (Konoshima et al., 1996)
(Figure 11).
Figure 11: Ginsenosides from Ginseng
Prevention and treatment of male osteoporosis due to androgen deficiency by using the medicinal plant: Eurycoma
longifolia
Osteoporosis in elderly men is now becoming an alarming health issue due to its relation with a higher mortality
rate compared to osteoporosis in women. Androgen deficiency (hypogonadism) is one of the major factors of male
osteoporosis and it can be treated with testosterone replacement therapy (TRT). However, one medicinal plant, Eurycoma
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longifolia Jack (EL), can be used as an alternative treatment to prevent and treat male osteoporosis without causing the side
effects associated with TRT. EL exerts proandrogenic effects that enhance testosterone level, as well as stimulate osteoblast
proliferation and osteoclast apoptosis. This will maintain bone remodelling activity and reduce bone loss. Phytochemical
components of EL may also prevent osteoporosis via its antioxidative property (Figure 12). Hence, EL has the potential as a
complementary treatment for male osteoporosis (Effendy et al., 2012).
Figure 12: Some of the chemical constituents isolated from the root of Eurycoma longifolia Jack (Source: Effendy et al.,
2012)
Plants used for the prevention of Coronary Heart Disease (CHD)
Coronary Heart Disease (CHD) is the primary contributor to morbidity and mortality worldwide. A great deal of
research is now focused on identifying new therapeutic alternatives to prevent and treat CHD. The most consistent
recommendations from a Public Health perspective involve multiple changes in diet and exercise. Medicinal plants are also a
viable option for its prevention and treatment. Clinical and preclinical data on some medicinal plants used as dietary
supplements show that they may be useful in the strategies to reduce the prevalence and mortality of CHD either in the
general population or in the subsets of individuals at high risk. Such plants include, for example, artichoke, garlic, gingko,
guggul, hawthorn and tea.
Artichoke Cynara scolymus L. (Family Asteraceae)
Dried leaves and lower part of the flower of this plant contain 6% phenolic acids, 5% sequiterpene latones. Three
sesquiterpenes, cynaropicrin, aguerine B, and grosheimin were isolated as the active components of the artichoke extract
which reduced serum triglyceride levels in olive oil-loaded mice. Aqueous and ethanolic extracts of artichoke also reduced
intracellular oxidative stress stimulated by inflammatory mediators such as tumour necrosis factor alpha (TNFa) and
lipopolysacchaide (LPS), as well as ox-low density lipoprotein (ox-LDL) in endothelial cells and monocytes.
Garlic (Alium sativum, (Family Liliaceae)
Over 35 randomised clinical trials on garlic were carried out to investigate the effect of garlic on cardiovascular end
points. Overall, there is evidence from randomised controlled trials (RCT) in adults that the use of garlic preparations can
lead to a small but statistically significant reduction in total cholesterol levels compared with controls.
Guggul Commiphora mukul.(Jacq) Engler,(Family Burseraceae)
The Mukul Myrrh tree has been used as far back as 600 BC. According to the recent WHO Monograph for guggul,
the plant is useful for the treatment of hyperlipideamia and hypercholesterolemia. The plant sterols, E- and Z-guggulesterone,
are believed to be the bioactive compounds.
Strategies for combating micronutrient deficiencies: Food-based approaches
Multiple micronutrient deficiencies abound in developing countries (Ramakrishnan, 2002). They are caused by
inadequate intakes but genetic, parasitic and infectious diseases may also play a role (Fishman, et al., 2000; Stoltzfus, 2001).
Micro nutrient deficiencies can have major adverse health consequences, contributing to impairment in growth, immune
competence, mental and physical development, and poor reproductive outcomes (Viteri and Gonzales, 2002) that cannot
always be reversed by nutrition interventions. Inadequate intakes of certain micronutrients such as iodine, selenium and zinc
can also be exacerbated by environmental factors, as their content in plant based foods is dependent on soil trace elements
(Gibson and Hotz, 2001).
There is therefore a strong need for strategies to reduce micronutrient deficiencies in developing countries.
Strategies commonly used are supplementation and food-based approaches, preferably in conjunction with public health
interventions such as promotion and support of breast feeding and control of infectious and parasitic diseases. Fruits and
vegetables are a good source of vitamins and minerals. Faber and Laurie (2011) described a home garden strategy that
integrates gardening activities with nutrition education, using community based growth monitoring as an entry point in South
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Africa. A positive effect was observed that Provitamin A rich vegetables and fruits contributed significantly towards
achieving the recommended dietary intake of Vitamin A and other micronutrients. They concluded that home gardening is a
long term strategy that contributes to combating Vitamin A and other nutritional deficiencies. This is only one of the several
individual investigations reported by Thompson and Amoroso (2011) to pinpoint the fact that food based strategies are
viable, sustainable and long term solutions to overcoming micronutrient malnutrition.
The strategy of using antioxidant activity of medicinal plants in prevention of diseases
Oxidative stress, caused by reactive oxygen species, plays an important role in many chronic and degenerative
diseases, such as atherosclerosis, ischemic heart disease, cancer, diabetes mellitus, neurodegenerative diseases and ageing
(Azizova, 2002). The body’s non-enzymatic antioxidant defence system includes some antioxidants, such as vitamin C,
vitamin E, vitamin K and glutathione. Some synthetic antioxidants, widely used in food industry to protect food from
oxidation and spoiling, are harmful because of their potential toxicity and carcinogenicity (Botterweck et al., 2000).
However, natural antioxidants in fruits and vegetables are inversely related with the risk of the chronic diseases mentioned
above (Leifert and Abeywardena, 2008). Natural antioxidants, therefore, provide alternative strategy to prevention as well as
treatment of these diseases. Phenolic compounds because of their oxidative activity are potential agents for preventing and
treating many oxidative stress-related diseases. The antioxidant activity of polyphenols is mainly due to their redox
properties, which allow them to act as reducing agents, hydrogen donors, singlet oxygen quenchers, metal chelators and
reductants of ferryl hemoglobin (Kratchanova et al., 2010). Some medicinal plants possess more potent antioxidant activity
than common dietary plants (Cai et al., 2004). Therefore, their extract, if not toxic, can serve as food additive and can be
used for disease prevention (Liu, 2003; Liu et al., 2008).
Oral Diseases prevention with medicinal plants
Oral diseases are major health problems with dental caries and periodontal diseases among the most prevalent,
preventable global infectious diseases. Oral health influences the general quality of life and poor oral health is linked to
chronic conditions and systemic diseases. The association between oral diseases and the oral microbiota is well established.
Although there are more than 750 species of bacteria that inhabit the oral cavity, most are normal commensals and only a few
are implicated in oral diseases. The development of dental caries involves acidogenic and aciduric Gram-positive bacteria
(mutans streptococci, lactobacilli and actinomycetes). Periodontal diseases have been linked to anaerobic Gram-negative
bacteria (Porphyromonas gingivalis, Actinobacillus, Prevotella and Fusobacterium). Given the incidence of oral disease,
increased resistance by bacteria to antibiotics, adverse effects of some antibacterial agents currently used in dentistry and
financial considerations in developing countries, there is a need for alternative prevention and treatment options that are safe,
effective and economical. While several agents are commercially available, these chemicals can alter oral microbiota and
have undesirable side-effects, including tooth staining. Hence, the search for alternative products continues and natural
phytochemicals isolated from plants used as traditional medicines are considered as good alternatives. Palombo (2011)
concluded that there is considerable evidence that plant extracts, essential oils and purified phytochemicals have the potential
to be developed into agents that can be used as preventive or treatment therapies for oral diseases. While it is encouraging to
see a number of clinical trials of such products, further studies of the safety and efficacy of these agents will be important to
establish whether they offer therapeutic benefits, either alone or in combination with conventional therapies, that can help to
reduce the overall burden of oral diseases worldwide. In particular, studies that address issues such as adequate statistical
power, blinding, standardisation of extracts or purified compounds, and quality control would be of great value (Palombo,
2011)
Some miscellaneous practices for the prevention of diseases with medicinal plants in Africa
According to Koumare (2008) repeated sore throat especially in children is often prevented in Mali and other
African countries by using gargles made with the following plants: Spilanthes sp, Guiera senegalensis and Waltheria indica.
Traore (1975) had also compiled some cultural practices of the Malian people in the prevention of dental problems with
medicinal plants (Troure, 1975). The efficacy of chewing sticks used for preventive dental care had been reported by
Sofowora and others (Sofowora, 2008). It is common knowledge among women in Africa, especially in Burkina Faso, to rub
the skin of new borne babies with various medicinal plants (e.g. Pterocarpus osun) soaked in oil to prevent them from
bacterial infection as they are carried by various people. Also, because the mothers do not know whether the visitors carrying
the newborn have evil intentions, the preparation with which the baby is rubbed often contains plants with occult powers to
ward off any spiritual attack on the baby by visitors. Various antenatal practices using medicinal plants exist in Africa. The
pregnant woman is made to bathe in some decoctions of herbs and required to drink a little of it periodically throughout the
period of pregnancy to sustain her. There are also herbs to be taken just before delivery to hasten or to ease delivery.
However, the use of herbs in late pregnancy could be for their oxytocic properties. Some preparations for preventing road
accidents exist in Africa just as there are similar preparations utilising the occult power of herbs to eject a person from an
accident vehicle before the accident (Egbe in Yoruba). These latter preventive uses of medicinal plants involving the occult
power of herbs may be beyond present capabilities of scientific experimentation to prove their efficacy.
Conclusions
Efforts must be geared towards measures that will enhance the effectiveness, efficacy and rational use of medicinal
plants, especially through the integration into national, regional and local health policies and programmes. Most African
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countries, for example, hinge their health care system on the Primary Health Care (PHC) strategy and it is necessary to
incorporate the use of medicinal plants into all the components of PHC in these countries. The following are also
recommended: a) Collation of data from books, research articles, conducting of ethnobotanical surveys (because Africans
have only recently started documentation of medicinal plants and their uses; oral tradition had been the mainstay) specifically
to look for plants used in preventing diseases in our communities as was done in Muktipara village of Sri Lanka. Database
searches on medicinal plants will also yield useful results (Table 1); b) collaborative research with Institutes for preventive
medicine as well as departments of preventive dentistry in teaching hospitals; and c) coordination of the research to avoid
duplication of efforts.
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Table 1: plants with potentials in preventive medicine practice
S/
No
Plant Family Common
Names
Local Names Parts Used Chemical
Constituents
Action References
1 Hygrophila
auriculata
Acanthaceae Indian paint
brush
Hausa: zazargiwa,
kayarukumi
Whole plant Steroids, Alkaloids Antibiotic Odugbemi (2006)
2 Peristrophe
bicalyculata
Acanthaceae Tabanin dawaki,
hargowandoki
Whole plant Alkaloids, Essential
oils, Fatty acids
Antimicrobial, it prevent
Tuberculosis
Okujagu (2008)
3 Amaranthus
spinosus L.
Amaranthaceae Thorny pig
weed
Hausa :zaaki banza
mai
kaya,Igbo:inine
ogwu,yoruba:tete
kekere
Whole plant Tannins,saponins,amin
o acids,methyl
derivative,cholesterol,
oleanolic
acid,stigmasterol,camp
esterol
Antipyretic Okujagu (2008)
4 Celosia isertii
C.C. Townsend
Amaranthaceae Hausa: Nannaho
Igbo: Eli-emi Onu
Yoruba: Ajifowo
Whole plant Amaranthin celosianin
Betanin
Antihelmintic Okujagu (2008)
5 Mangifera indica Anacardiaceae Mango Hausa: mangwaro
Igbo: mangoro
Stem bark,
leaves, fruit
Mangiferine Anti-emetic, Anti-inflammatory Okujagu (2008)
6 Spondias mombin
L.
Anacardiaceae Akika (Yoruba),
Ijikere (Igbo)
Leaves Tannins, phenolic
esters, Alkaloids,
saponin
Antiviral
Antibacterial
Okwu and Okwu (2004)
7 Xylopia aethiopica
(Dunal) A.Rich.
Annonaceae Ethiopian
pepper seed
Sesedo (Yoruba),
Uda (Igbo)
Fruits Volatile oil Antimicrobial,
8 Catharanthus
roseus L. G. Don
Apocynaceae Rose
periwinkle
Apabida (Yoruba) Leaves Vincrstine, vinblastine Anti-leukaemic,
anti-cancer, antihypertensive
Elujoba et al, (2005)
9 Rauwolfia
vomitoriaAfz
Or R. serpentine
(L.) Benth ex. Kurz
Apocynaceae Serpent wood Asofeyeje
(Yoruba), Akata
(Igbo)
Leaves,
Seeds
Reserpine,
deserpidine,
rescinamine,
yohimbine
Antihypertensive Kokwaro, (1993);
Sofowora (2008)
10 Crytolopsis
sanguinolenta
(lindl(
Apocynaceae Igbo: oba
Yoruba: igisoba
Fruit hydrocyanic acids Anti-tumor, anti-inflammatory
11 Aristolochia albida
Duchartre
Aristolochiaceae Dutchman
pipe
Hausa :duman
dutse,Igbo:isi
okuko,Yoruba:para
n funfun
root Aristolochic
acids,aristolachine,aris
tinic acids,aristidinic
acids
Anthelmintic,anti-inflammatory Okujagu (2008)
12 Ageratum
conyzoides L.
Asteraceae Goat weed Imiesu (Yoruba) Whole plant Phenols, Alkaloids Antimicrobial, anti-inflammatory,
anti-allergic properties.
Kokwaro (1993)
13 Kigelia Africana
(Lam.) Benth
Bignoniaceae Sausage tree Pandoro
(Yoruba) Ishi
(Igbo), Rahaina,
nonon giwa
(Hausa)
Bark, Seed. Naphthoquinones,
Iridoids,
Anti-malaria
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14 Adansonia digitata
L.
Bombacaceae Baobab,
Monkey
bread
Kuka (Hausa), Osa
(Yoruba) Osi
(Edo), Oyili-akpu
(Igbo), Kuwa
(kanuri)
Root, bark,
seed, leaves,
flower.
Hydroquinone,
proanthocyanidins
Anti- inflammation
15 Afzelia africana
Smith
Caesalpiniaceae Hausa: kawo
Igbo: Akpalata
Yoruba: Api
Edo: Ariyan
Efik: Enyin
mbukpo
Bark Alkaloids, Tanins Antihelmintic Okujagu (2008)
16 Cassia alataL. Caesalpinaceae Cassia Asunran (Yoruba) Leaves Alkaloids, Saponins,
Tannins,
anthracionones and
carbohydrates.
Antiseptic, laxative and it also
inhibits fungal growth
Gill (1992); Sule et al
(2010)
17 Cassia tora Caesalpinaceae Hausa: Talasa
Yoruba Aborere
Whole plant Tannis, Alkaloids,
Anthraquinones,
Glycosides, Oil,
Hydrocyanic acid,
fatty acid
Antimicrobial Activity Sofowora (2008)
18 Daniella oliveri
(Rolfe)
Caesalpiniaceae Balsam tree Hausa: maje
Igbo: Agba
Yoruba: Ojia, iya
Gum of bark Alkaloid, Essential oil,
tannin and oleoresin
Anti-parasite Onwukaeme (1993)
19 Cleome viscose L. Capparidaceae Spider plant Hausa
:tafarnuwan,Igbo;k
eerem
kerem,Yoruba
a:ekuya
Seeds, root Coumarino-
lignans,cleomiscosin,
marcrocyclic
diterpenes
Antiscorbutic,anthelmintic Okujagu (2008)
20 Carica papaya L. Caricaseae Paw paw Ibepe (Yoruba) Fruits, latex,
leaves
Alkaloids, Flavonoids,
Triterpenes
anthelmintic,
antifungal
Gill (1992).
21 Bryophyllum
pinnatum Lam
Oken
Crassulaceae Ressurection
plant, Life
plant
Eru-odundun,
Abomoda
(Yoruba), Odaa
opue (Igbo)
Leaves,
Roots, Leaf
sap
alkaloids, flavonoids
and essential oils
Antifungal, Antimicrobial,
Anticancer. antihypertensive activity,
prevent and treat Leishmaniasis,
protect against
chemically induced anaphylactic
reactions
Ghasi et al (2011)
22 Mormodica
charantia
Curcubitaceae Bitter lemon Hausa Garapunu Fruit Steroids Antidiabetic, Antioxidant Abe (1974)
23. Telferia
occidentalis
Curcubitaceae Fluted
pumpkin
Igbo: ugu Seeds Steriods, tannic acid Prevention of adnopause, prevention
of anaemia
Tan (2002)
24 Acalypha
godseffiana pax
Euphorbiaceae Golden
acalypha
Yoruba: Jinwinni Leaf
Poultice
antibiotic,
bacteristatic,
fungistatic
Antibacterial Odugbemi (2006)
25 Acalypha
wilkesiana Müll.-
Euphorbiaceae Copper leaf,
beef steak
Yoruba: Jinwinni,
(Ijebu) aworoso
Leaf antibiotic,
bacteristatic,
antimicrobials Odugbemi (2006)
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Arg. plant fungistatic
26 Acalypha
wilkesiana
Euphobiaceae Acalypha Hausa: Jinwinni,
Igbo: Jiwene,
Yoruba aworoso
leaf Ethanol Antmicrobial Odugbemi (2006)
27 Alchornea
cordifolia (Schum.
& Thonn.)
Euphorbiaceae Christmas
bush, Oliver
Yoruba: èpa, esin,
Hausa: bambami,
Igbo: ubebe,
Leaf Alkaloids glycosides,
saponins, steroids
tannins, astringents
Antiaborifacients Burkill (1985):
28 Euphorbia hirta l Euphobiaceae Hausa: udani
Igbo:
Whole plant Alkaloid, glycoside,
tarderpenoids, sterols
Antibacterial, anti-diarrhoea, Anti-
asthmatic,
Onwukaeme (1993)
29 Jatrophacurcas L. Euphorbiaceae Red fig nut
flower
Lapalapa (Yoruba) Leaves Volatile oil, Curcin,
Saponins, Tannins
Antimicrobial, antiseptic Thomas (1989)
30 Mallotus
oppositifolius
(Geisel) mull. Arg.
Euphorbiaceae Ukpo (Igbo), Kafar
mutuwaa (Hausa),
Eja (Yoruba)
Leaves Alkaliods, phenols,
anthocyanins,
butacyanin,
flavonoids, steroids
and tannins
Anti-malarial and inhibits fungal
growth.
Farombi et al.,
2001
31 Phyllanthus amarus Euphorbiaceae Stone breaker Ite kwonwa nazu
(Igbo), Geeron
tsutsaayee (Hausa),
Eyin olubi
(Yoruba), Ebe-
benizo (Benin).
Whole plant Insulin, Saponin,
Tannins.
32 Ocimum
gratissimum L
Lamiaceae Clove basil,
Sweet basil,
tea bush,
Scent leaf or
fever plant
Efinrin (Yoruba),
Nchu-anwu, Ahuji
(Igbo), Daidoya
(Hausa)
Leaves,
Essential
oils
Curcumin, flavonoids,
isoflavone, flavones,
anthocyanin, catechin
and isocatechin;
Alkaloids, Saponins,
Cardiac glycosides and
Anthraquinones
It prevents breast cancer and fat
accumulation. It inhibits growth of
disease causative microorganisms
(antimicrobial). It has antioxidant
activity and also preventing the
formation of oxidized Low-density
Lipoprotein (LDL), which is
considered to induce cardiovascular
disease
Obho (2006) Amic et
al., (2003); Nwinyi et.
al. (2009);
33 Allium cepa Linn Liliaceae Onions Alubosa (Yoruba) Bulbs Alicin, quercetin, allyl
propyl disulfide
Prevents irregular heart beat and
abnormal blood pressure. It also
prevents cancers, coronary heart
disease, arteriosclerosis (hardening of
the arteries), bronchitis, dry or
stubborn cough and blood clots.
Ozougwu and Eyo
(2011)
34 Allium sativumL. Liliaceae Garlic Aayu (Yoruba) Bulbs peptides, steroids,
terpenoids, flavonoids,
and phenols
Anti-bacteria and also prevents high
blood pressure
Gill, 1992
35 Erythrophleum
suaveolens Guill.
&
Perr.
Leguminosae sassy,
sasswood, red
water tree and
ordeal tree
Obo Erunobo, olu-
obo,
Ajeku, Obo
(Yoruba), Gwaska
(Hausa), inyi,akpa.
Stem bark Saponins Anti-oxidants, antiviral,
Antihelminthic, antimicrobial,
anticancer
Lawal et al, 2010;
Akinpelu et al, 2012
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(Igbo)
36 Abelmoschus
esculentus (Linn.)
Malvaceae Okro, lady’s
fingers.
Yoruba: ila Fruit alkaloids. uricant.
aromatic substances
antibiotic, bacteristatic, fungistatic Odugbemi (2006)
37 Hibiscus sabdariffa
L.
Malvaceae Red Sorrel Yakuwa (Hausa),
Karasu (Kanuri),
Tabwa (babur)
Whole plant Protocatechuic acid Anti-malaria
38 Sida acuta Burm. F Malvaceae Horn bean
leaf
Esoketu, Iseketu
(Yoruba)
Leaves,
Roots
Alkaloids, Phenols,
Fatty acids,
Coumarins, Sterols,
Triterpenoids
Antipyretic and has inhibitory activity
against disease causing bacteria
Iroha et al 2009
39 Azadirachtaindica
(A.Juss.)
Meliaceae Neem Dongoyaro leaves Quinine Anti-malaria. Lawal et al, 2010
40 Azadirachta indica
A.Juss.
Meliaceae Neem Dongoyaro Leaves Quinine Anti malaria, insecticide Lawal et al, 2010
41 Acacia polyacantha
Wild.
Mimosaceae Edi (Yoruba) Bark Alkaloid,
Tannins,Saponins,
Resins
Anti-malaria
42 Pentacletha
macrophylla Benth
Mimosoideae Oil bean tree Igbo: ugba,
ukpaka, akpaka
Ijaw: ukpakara
Yoruba Apara
Leaves Saponin, tannins,
paucine
Anticarcinogenic Onwukaeme (1993)
43 Artocarpus
heterophyllus Lam
Moraceae Jack fruit Fruits dihydromorin,
steppogenin,
norartocarpetin,
artocarpanone, and
artocarpesin
Anti-ulcer Lawal et al, 2010
44 Moringa oleifera
Lam.
Moringaceae Drumstick
tree
Moringa Leaves,
Seeds
Saponins, Riboflavin,
Sterols
Antioxidants, antimicrobial Odugbemi (2006)
45 Passiflora foetida
L
Passifloraceae Stinking
passion
flower
Nine-nine Roots,
Leaves,
Fruits
chrysoeriol, apigenin,
luteolin, kaempferol,
isoschaftoside, 2''-
xylosylvitexin,
isovitexin and vitexin
Antispasmodic, antibacterial,
antihypertension, antiproliferative
activity on human breast
adenocarcinoma
Moongkarndi et al.,
2004
46 Cymbopogon
citrates
Poaceae Lemon grass Kooko oba
(Yoruba) Isauri
(Hausa), Achara
ehi (Igbo Ikon
(Efik).
Leaves Essential oils (e.g
Citral), Limonine,
Camphene, citronella,
Geraniol, Alkaloids.
Anti-malaria . Odugbemi (2006)
47 Piper guineense
Schum
Piperaceae African black
pepper
Iyere, Ata-iyere
(Yoruba)
Fruits,
Leaves,
Seeds
alkaloidal amides
(Piperanine,
dihydrowasanine,
isobutyl-(E,E)-2, 4-
decadienamide)
Antipyretic, Antiemetic,
antiparasitic,
antimicrobial and antifungal activities
Ngane et al., (2003);
Ekanem et al.,
(2004)
48 Piper nigrum L. Piperaceae Black pepper Uziza (Igbo), Iyere Fruits eugenol, kaempferol, It inhibits pro-inflammatory Shaba et al. (2012)
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(Yoruba), Masoro
(Hausa)
myrcene, piperine,
quercetin, chavicin
and rutin black pepper.
cytokines that are produced by
tumour cells (anti-tumourigenic). It is
also immunostimmulatory,
stomachic, carminative,
anticholestrolemic and anti-oxidant. It
also inhibits the growth of malaria
parasite.
49 Peperomia
Pellucida L.
Piperaceae pepper elder Bark alkaloids, flavonoids,
tannin, saponins and
Tepernoid
Prevents gout, anti-arthritic, Anti-
cancer, Antioxidant, antimicrobial,
antfungal
Odugbemi (2006)
50 Citrus aurantifolia Rutaceae Orange
(Lime)
Olome (Igbo),
Osan-wewe
(Yoruba) Lemun
tsami (Hausa),
Lemun tsamtsam
(Kanuri)
Fruit, Leaves Ascorbic acid,
asparagine, acetic acid,
essential oils.
Anti-malaria Odugbemi (2006)
51 Capsicum annum Solanaceae Ball pepper Hausa: kananan
barkomo
Yoruba: Ata wewe
Igbo: ose ogologo
Fruits, and
leaves
Capsaicin,
capsaicinoids
Antimicrobial, prevention of heart
attack and stroke
Odugbemi (2006)
52 Cola millenii
K.Schum
Sterculiaceae monkey cola Obi-edun (Yoruba) Fruits phytosterols,
polyphenols (tannins,
flavonoids), saponins,
alkaloids, saponin
glycosides,
steroids and
triterpenoids,
glycosides,
hydrolysable tannins,
phenols and volatile
oils
Antiviral, reduces the low density
lipoprotein, i.e. the cholesterol
involved in depositing fat in the
Arteries prevent blood clotting which
can reduce risk of heart attack or
stroke.
Lawal et al, 2010
53 Cucurma longa L. Zingiberaceae Tumeric Tumeric Roots Curcumin, Tumeric
oils, Terpenoids
It prevents cancerous growth. It also
aids digestion of fats. It helpful in
preventing the blockage of arteries
that can gradually cause a heart attack
or stroke
Odugbemi (2006)
54 Zingiber officinale
Roscoe
Zingiberaceae Ginger Ginger Rhizome Gingerols, shogaols,
zingerone and paradol
It prevents chilblains and circulatory
problems such as Raynaud’s disease.
It is highly antiseptic, activating
immunity and dispelling a whole
variety of bacterial and viral
infections. It also inhibits blood
clotting.
Ozougwu and Eyo
(2011)
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